Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment?

Background: Artemisinin-based treatment in malaria patients with abnormal hemoglobin may be ineffective because of their genetic particularity, which could lead to resistance. The main purpose of this study was to assess the effect of artemisinin derivatives on in vivo parasite clearance according t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gbessi, Eric A., Toure, Offianan A., Gnondjui, Albert, Koui, Tossea S., Coulibaly, Baba, Ako, Berenger A., Tiacoh, Nguessan L., Assi, Serge-Brice, Sanogo, Ibrahima, Sokouri, Didier-Paulin, Jambou, Ronan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475499/
https://www.ncbi.nlm.nih.gov/pubmed/34569928
http://dx.doi.org/10.1051/parasite/2021063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475499/
https://www.ncbi.nlm.nih.gov/pubmed/34569928
http://dx.doi.org/10.1051/parasite/2021063

Ejemplares similares